Simba Gill - 03 Feb 2026 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Reporting relationship: Director
Issuer ticker: SER
Reported as of: 03 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Feb 2026, 08:24:46 UTC
Prior SEC filing: 17 Jun 2025
Next SEC filing: 25 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Simba Gill

Key filing fact

Simba Gill filed Form 4 for Serina Therapeutics, Inc. (SER) on 17 Feb 2026.

Key facts

This page summarizes Simba Gill's Form 4 filing for Serina Therapeutics, Inc. (SER).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Feb 2026, 08:24.

Change

Previous filing in this sequence was filed on 17 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001180763 Primary reporting owner

GILL SIMBA

Relationship: Director
Address: 601 GENOME WAY, SUITE 2001, HUNTSVILLE
Signature: /s/ Simba Gill
Signature date: 17 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SER transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +92,000
Change %
Price: $0.000000
Shares after: 92,000
Date: 03 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 92,000
Exercise price: $2.76
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested.